SARS-CoV-2 & FLU A/B Rapid Antigen Test Kit- Vitrosens Biotechnology
https://vitrosens.com/wp-content/uploads/2023/11/VSCD08-1.png

SARS-CoV-2 & FLU A/B Rapid Antigen Test Kit

It is created as in vitro differentiative detection for SARS-CoV-2 & FLU A/B antigens in human nasopharyngeal and nasal swab samples.

Advantages

– For professional use only
– Already filled buffer tubes
– 2 sampling options
– Easy-to-follow procedure
– Variant detection
– Accurate and rapid results

Box Content

– Test Cassette
– Tube
– Swab
– Dropper
– User Manual

Specification

Intended use Detection of SARS-CoV-2 antigen
Storage 2-30℃ / 35.6-86℉
Specimen type Nasal swab
Time to result 15-30 minutes
Shelf life 24 months
Sensitivity 93.1%
Specificity 100.0%

Video

.embed-container { position: relative; padding-bottom: 56.25%; height: 0; overflow: hidden; max-width: 100%; } .embed-container iframe, .embed-container object, .embed-container embed { position: absolute; top: 0; left: 0; width: 100%; height: 100%; }

Order Information

 Ref. No.
Target
Specimen
Kit Size
Certifications

VSCD08

SARS-CoV-2 & FLU A/B Antigens

NP

25  T

celogo

NP: Nasopharyngeal

footer-logo

Vitrosens Biotechnology is a high-tech company in Turkey founded for the development, manufacture, and delivery of in vitro diagnostic devices (IVD) to the world.
Follow USVITROSENS on Social Media
For our updated news and products follow us on social media.

vitrosens logo new

Vitrosens Biotechnology is a high-tech company in Turkey founded for the development, manufacture, and delivery of in vitro diagnostic devices (IVD) to the world.
vitrosens.com
Human Health
Animal Health
Follow USVITROSENS on Social Media
For our updated news and products follow us on social media.